I was one of their first customers and the progress @mijustin and @jonbuda have made working mostly part-time has been crazy.
Now both are full-time. Follow them on @buildyoursaas
1/ "Hardcore Year" (https://t.co/cjx7HfGeEK)
— Reilly Chase\u2601\ufe0f\u2601\ufe0f\u2601\ufe0f (@_rchase_) July 31, 2019
MRR in July:
\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593\u2593 $9,109 of $8,333 goal (109%)
Totals@hostifi_net $8,463@ghostifi_net $361@locklinnetworks $125@captifi_net $147@patreon $13
I reached my goal for the year! \U0001f942\U0001f37e
Details in thread \U0001f447 pic.twitter.com/cUEeiADDAk
This year is flying by. How am I doing a July report already? Here it is: Closet Tools' July open stats:
— Jordan O'Connor (@unindie) August 1, 2019
MRR: $11106.28 (+11.43%)
Organic Search: 3958 (+20.45%)
New Trials: 154 (-8.33%)
Less trials, more revenue (churn is going down!). The focus for July was feature stability. pic.twitter.com/4YRpkPvKxo
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz